Live feed
·
INSIDERFilingvia Quantisnow
Champions Oncology Inc. logo

Champions Oncology (CSBR) director Breitfeld received 8,045 shares

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Philip P. Breitfeld (director at Champions Oncology Inc., CSBR) reported that they received 8,045 shares on Nov 5, 2021.

Reporting person
Breitfeld Philip P.

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Nov 5, 2021Grant or award (A)Option to purchase Common StockOn 8,045 Common Stock1+8,045$10.10$81.3K8,045 direct

Holdings before and after

  • Option to purchase Common Stock: 0 to 8,045 direct

Footnotes from the filing

  1. 1. The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2021, February 5, 2022, May 5, 2022 and August 5,2022, respectively.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Breitfeld report in this CSBR Form 4?

Philip P. Breitfeld (director at Champions Oncology Inc., CSBR) reported that they received 8,045 shares on Nov 5, 2021.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for CSBR

Earlier insider filings at CSBR

Quantisnow market dataNASDAQ
Champions Oncology Inc. logo
CSBR
Champions Oncology Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for CSBR

Follow CSBR and get a push notification the moment its next story breaks.

Full CSBR profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CSBR (Champions Oncology Inc.) and more on Quantisnow.